A dominant interfering Myb mutant causes apoptosis in T cells

Genes and Development

Volumn 10, Issue 21, 1996, Pages 2732-2744

  Taylor, Deborah ^a   Badiani, Pratipa ^a   Weston, Kathleen ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

apoptosis; bcl 2; Myb; T cells; transcriptional control

Indexed keywords

MUTANT PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0029824846     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.21.2732     Document Type: Article

References (63)

1. Alitalo, K., R. Winqvist, C.C. Lin, A. de la Chapelle, M. Schwab, and J.M. Bishop. 1984. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc. Natl. Acad. Sci, 81: 4534-4538.
2. Arsura, M., M. Introna, F. Passerini, A. Mantovani, and J. Golay. 1992. B-myb antisense oligonucleotides inhibit proliferation of human hematopoietic cell lines. Blood 79: 2708-2716.
3. Badiani, P., P. Corbella, D. Kioussis, J. Marvel, and K. Weston. 1994. Dominant interfering alleles define a role for c-Myb in T cell development. Genes & Dev. 8: 770-782.
4. Barletta, C., P.-G. Pelicci, L.C. Kenyon, S.D. Smith, and R. Dalla-Favera. 1987. Relationship between the c-myb locus and the 6q- chromosomal aberration in leukemias and lymphomas. Science 235: 1064-1067.
5. Bies, J. and L. Wolff. 1995. Acceleration of apoptosis in transforming growth factor beta 1-treated M1 cells ectopically expressing B-myb. Cancer Res. 55: 501-504.
6. Bies, J., B. Hoffman, A. Amanullah, T. Giese, and L. Wolff. 1996. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells. Oncogene 12: 355-363.
7. Bloomfield, C.D., D.C. Arthur, G. Frizzera, E.G. Levine, B.A. Peterson, and K.J. Gajl-Peczalska. 1983. Nonrandom chromosome abnormalities in lymphoma. Cancer Res. 43: 2975-2984.
8. Burgess, T.L., E.F. Fisher, S.L. Ross, I.V. Bready, Y.X. Qian, L.A. Bayewitch, A.M. Cohen, C.J. Herrera, S.S. Hu, T.B. Kramer, F.D. Lott, F.H. Martin, G.F. Pierce, L. Simonet, and C.L. Farrell. 1995. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. Natl. Acad. Sci. 92: 4051-4055.
9. Calabretta, B. 1991. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: Biological and therapeutic implications. Cancer Res. 51: 4505-4510.
10. Chen, H.M. and L.M. Boxer. 1995. III binding sites are negative regulators of bcl-2 expression in pre-B cells. Mol. Cell. Biol. 15: 3840-3847.
11. Coligan, J.E., A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, eds. 1991. Current protocols in immunology. Greene Publishing Associates, New York, NY.
12. Crabtree, G.R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243: 355-360.
13. Craig, R. 1995. The BCL-2 gene family. Semin. Cancer Biol. 6: 35-43.
14. Evan, G.I., G.K. Lewis, G. Ramsay, and J.M. Bishop. 1985. Isolation of monoclonal antibodies specific for the human c-myc proto-oncogene product. Mol. Cell. Biol. 5: 3610-3616.
15. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Perm, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
16. Fang, W., J.J. Rivard, D.L. Mueller, and T.W. Behrens. 1994. Cloning and molecular characterization of mouse bcl-x in B and T lymphocytes. J. Immunol 153: 4388-4398.
17. Foos, G., S. Grimm, and K.H. Klempnauer. 1992. Functional antagonism between members of the myb family: B-myb inhibits v-myb-induced gene activation. EMBO J. 11: 4619-4629.
18. Golay, J., A. Capucci, M. Arsura, M. Castellano, V. Rizzo, and M. Introna. 1991. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood 77: 149-158.
19. Gonzalez Garcia, M., I. Garcia, L. Ding, S. O'Shea, L.H. Boise, C.B. Thompson, and G. Nunez. 1995. bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. 92: 4304-4308.
20. Graf, T. 1992. Myb: A transcriptional activator linking proliferation and differentiation in hematopoietic cells. Curr. Opin. Genet. Dev. 2: 249-255.
21. Harrington, E.A., M.R. Bennett, A. Fanidi, and G.I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13: 3286-295.
22. Herrmann, M., H.-M. Lorenz, R. Voll, M. Grunke, W. Woith, and J.R. Kalden. 1994. A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res. 22: 5506-5507.
23. Hockenbery, D.M., M. Zutter, W. Hickey, M. Nahm, and S.J. Korsmeyer. 1991. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. 88: 6961-6965.
24. Kishimoto, H., C.D. Surh, and J. Sprent. 1995. Upregulation of surface markers on dying thymocytes. J. Exp. Med. 181: 649-655.
25. Korsmeyer, S.J. 1992. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu. Rev. Immunol. 10: 785-807.
26. Krieg, J., M. Oelgeschlager, R. Janknecht, and B. Luscher. 1995. High-affinity DNA-binding of native full-length c-myb and differentially proteolytic sensitivity of its N-terminal and C-terminal domains. Oncogene 10: 2221-2228.
27. Lam, E.W. and R.J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12: 2705-2713.
28. Lam, E., J. Bennett, and R. Watson. 1995. Cell-cycle regulation of human B-Myb transcription. Gene 160: 277-281.
29. 1 phase. Proc. Natl. Acad. Sci. 89: 9210-9214.
30. + stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1: 197-205.
31. Littlewood, T.D., D.C. Hancock, P.S. Danielian, M.G. Parker, and G.I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23: 1686-1690.
32. Melton, D.A., P.A. Krieg, M. Rebagliati, T. Maniatis, K. Zinn, and M.R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12: 7035-7056.
33. Mettus, R.V., J. Litvin, A. Wali, A. Toscani, K. Latham, K. Hatton, and E.P. Reddy. 1994. Murine A-myb: Evidence for differential splicing and tissue-specific expression. Oncogene 9: 3077-3086.
34. Mountz, J.D., A.D. Steinberg, D.M. Klinman, and H.R. Smith. 1984. Autoimmunity and increased c-myb transcription. Science 226: 1087-1089.
35. Mucenski, M.L., K. McLain, A.B. Kier, S.H. Swerdlow, CM. Schreiner, T.A. Miller, D.W. Pietryga, W.J. Scott, Jr. and S.S. Potter. 1991. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65: 677-689.
36. Nagata, S. and P. Golstein. 1995. The Fas death factor. Science 267: 1449-1456.
37. Nakagoshi, H., C. Kanei Ishii, T. Sawazaki, G. Mizuguchi, and S. Ishii. 1992. Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7: 1233-1240.
38. Negrini, M., E. Silini, C. Kozak, Y. Tsujimoto, and C.M. Croce. 1987. Molecular analysis of mbcl-2: Structure and expression of the marine gene homologous to the human gene involved in follicular lymphoma. Cell 49: 455-463.
39. Ness, S.A., A. Marknell, and T. Graf. 1989. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59: 1115-1125.
40. Ohyashiki, K., J.H. Ohyashiki, A.J. Kinniburgh, K. Toyama, H. Ito, J. Minowada, and A. Sandberg. 1988. myb oncogene in human hematopoietic neoplasia with 6q- anomaly. Cancer Genet. Cytogenet. 33: 83-92.
41. Orlic, D., S. Anderson, L.G. Biesecker, B.P. Sorrentino, and D.M. Bodine. 1995. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc. Natl. Acad. Sci. 92: 4601-4605.
42. Pelicci, P.-G., L. Lanfrancone, M.D. Brathwaite, S.R. Wolman, and R. Dalla-Favera. 1984. Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 224: 1117-1121.
43. Reiss, K., A. Ferber, S. Travail, P. Porcu, P.D. Phillips, and R. Baserga. 1991. The protooncogene c-myb increases the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism. Cancel Res. 51: 5997-6000.
44. Roberts, S. and D.L. Bentley. 1992. Distinct modes of transcription read through or terminate at the c-myc attenuator. EMBO J. 11: 1085-1093.
45. Sala, A. and B. Calabretta. 1992. Regulation of BALB/c 3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. Proc. Natl. Acad. Sci. 89: 10415-10419.
46. Selvakumaran, M., H.K. Lin, R.T. Sjin, J.C. Reed, D.A. Liebermann, and B. Hoffman. 1994. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells. Mol. Cell. Biol. 14: 2352-2360.
47. Sentman, C.L., J.R. Shutter, D. Hockenbery, O. Kanagawa, and S.J. Korsmeyer. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888.
48. Sheiness, D. and M. Gardinier. 1984. Expression of a proto-oncogene (proto-myb) in hemopoietic tissues of mice. Mol. Cell. Biol. 4: 1206-1212.
49. Sitzmann, J., K. Noben-Trauth, and K.-H. Klempnauer. 1995. Expression of mouse c-myb during embryonic development. Oncogene 11: 2273-2279.
50. Smarda, J. and J.S. Lipsick. 1994. c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed mono-blasts. Oncogene 9: 237-245.
51. 1 Progression and c-myb progression. Science 233: 203-206.
52. Strasser, A., A.W. Harris, D.L. Vaux, E. Webb, M.L. Bath, J.M. Adams, and S. Cory. 1990. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr. Top. Microbiol. Immunol. 166: 175-181.
53. Strasser, A., A.W. Harris, and S. Cory. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67: 889-899.
54. Strasser, A., A.W. Harris, D.C.S. Huang, P.H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14: 6136-6147.
55. Tashiro, S., Y. Takemoto, H. Handa, and S. Ishii. 1995. Cell type-specific trans-activation by the B-myb gene product: Requirement of the putative cofactor binding to the C-terminal conserved domain. Oncogene 10: 1699-1707.
56. Tesch, H., M. Michels, M. Jucker, I. Pahl, S. Klein, H. Bading, K. Moelling, and V. Diehl. 1992. Heterogeneous expression of c-myb protein in human leukemia detected by simultaneous two color flow cytometric analysis. Leuk. Res. 16: 265-274.
57. Thompson, M.A. and R.G. Ramsay. 1995. Myb: An old oncoprotein with new roles. Bioessays 17: 341-350.
58. Thompson, C.B., P.B. Challoner, P.E. Neiman, and M. Groudine. 1986. Expression of the c-myb proto-oncogene during cellular proliferation. Nature 319: 374-380.
59. Veis, D.J., C.L Sentman, E.A. Bach, and S.J. Korsmeyer. 1993. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151: 2546-2554.
60. Thompson, C.B., P.B. Challoner, P.E. Neiman, and M. Groudine. 1986. Expression of the c-myb proto-oncogene during cellular proliferation. Nature 319: 374-380.
61. Weston, K.M. 1990. The myb genes. Semin, in Cancer Biol 1: 371-382.
62. Weston, K. and J.M. Bishop. 1989. Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58: 85-93.
63. Young, R.L. and S.J. Korsmeyer. 1993. A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Mol. Cell. Biol. 13: 3686-3697.